文献速递关节外科

全因30天再入院率作为初次全髋与全膝关节置换术后医院绩效指标的有效性:一项系统综述

The Validity of All-Cause 30-Day Readmission Rate as a Hospital Performance Metric After Primary Total Hip and Knee Arthroplasty: A Systematic Review.
PubMed 文献 · J Arthroplasty · 2019-04-13

该系统综述纳入8篇文章,评估全因30天再入院率(ACRR)作为择期初次全髋关节置换术(THA)和全膝关节置换术(TKA)后医院绩效指标的有效性。结果显示ACRR与既有结局和过程复合指标相关性差,仅1.5%的再入院率变异归因于医院层面因素,患者相关因素如年龄和合并症影响更大。作者结论认为当前文献证据不足以支持用ACRR对医院进行经济处罚。

要点

  • ACRR与结局和过程复合指标相关性差,与死亡率呈弱正相关。
  • 仅1.5%的THA和TKA再入院率变异归因于医院层面因素。
  • 复合指标或手术再入院率可提高检测医院间重要变异的敏感度。

核心结论

  • 当前文献证据不足以支持在择期THA和TKA后使用ACRR对医院进行经济处罚。
  • 需进一步研究以定义可接受的变异范围。
  • 使用复合指标或手术再入院率可能提高检测医院间变异的能力。

研究设计与样本

  • 系统综述,检索MEDLINE、EMBASE和Health Management Information Consortium数据库自建库至2018年11月,并扫描所选文章的参考文献列表,最终文章列表由共识确定。
  • 共纳入8篇文章。

主要发现

  • ACRR与既有结局和过程复合指标的相关性差。
  • ACRR与死亡率呈弱正相关。
  • 仅1.5%的THA和TKA再入院率变异归因于医院层面因素,患者相关因素如年龄和合并症影响更大。
  • 使用复合结局指标(如结合再入院和死亡率)或考虑「手术」再入院率,提高了检测医院间重要变异的敏感度。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 当前文献证据不足以支持在择期THA和TKA后使用ACRR对医院进行经济处罚。
  • 需进一步研究以定义可接受的变异范围。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk-adjusted all-cause 30-day readmission rate (ACRR) following total hip arthroplasty (THA) and total knee arthroplasty (TKA) is currently used as a metric of hospital performance as part of the Hospital Readmissions Reduction Program. However, the extent to which it is determined by hospital-related factors and is therefore a fair method of determining reimbursement remains unclear. METHODS: Our aim was to systematically review the available literature pertaining to whether ACRR is a valid metric of hospital performance after elective primary THA or TKA as determined by (1) its association with other performance metrics, (2) the extent to which variation in ACRR can be explained by between-hospital variation, and (3) the relative importance of hospital-related versus surgeon- or patient-related factors in determining ACRR. The MEDLINE, EMBASE, and Health Management Information Consortium databases were searched from inception to November 2018 and reference lists of selected articles scanned. The final list of articles was determined by consensus. RESULTS: Eight articles were included. Correlation of ACRR with established composite metrics of both outcome and process measures was poor. There was a weak positive correlation between ACRR and mortality. Only 1.5% of the variation in readmission rates for THA and TKA was found to be attributable to hospital-level factors, with patient-related factors such as age and comorbidities having much greater influence. Use of composite outcome metrics, for example, combining readmission and mortality, or considering the "surgical" readmission rate, improved the sensitivity to detect important between-hospital variation. CONCLUSION: There is insufficient evidence in the current literature to justify the use of ACRR following elective THA and TKA for financially penalizing hospitals. Further work is needed to define what is acceptable variation. The use of a composite metric or surgical readmission rate may improve the ability to detect between-hospital variation.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Ali AM, Bottle A. The Validity of All-Cause 30-Day Readmission Rate as a Hospital Performance Metric After Primary Total Hip and Knee Arthroplasty: A Systematic Review. J Arthroplasty. 2019. PMID: 31072744. doi:10.1016/j.arth.2019.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。